Myovant Sciences Ltd. Income Tax Expense (Benefit) USD 2016 - 2022

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Myovant Sciences Ltd. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2016 to 2022.
  • Myovant Sciences Ltd. Income Tax Expense (Benefit) for the quarter ending December 31, 2022 was $1.21 M, a 307% increase year-over-year.
  • Myovant Sciences Ltd. Income Tax Expense (Benefit) for the twelve months ending December 31, 2022 was $21.5 M, a 968% increase year-over-year.
  • Myovant Sciences Ltd. annual Income Tax Expense (Benefit) for 2021 was $5.05 M, a 1402% increase from 2020.
  • Myovant Sciences Ltd. annual Income Tax Expense (Benefit) for 2020 was $336 K, a 55.8% decline from 2019.
  • Myovant Sciences Ltd. annual Income Tax Expense (Benefit) for 2019 was $761 K, a 59.9% increase from 2018.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $21.5 M $1.21 M +$909 K +307% Oct 1, 2022 Dec 31, 2022 10-Q 2023-01-26
Q3 2022 $20.6 M $8.11 M +$8.26 M Jul 1, 2022 Sep 30, 2022 10-Q 2022-10-26
Q2 2022 $12.3 M $8.16 M +$7.25 M +796% Apr 1, 2022 Jun 30, 2022 10-Q 2022-07-27
Q1 2022 $5.05 M $3.99 M +$3.04 M +319% Jan 1, 2022 Mar 31, 2022 10-K 2022-05-11
Q4 2021 $2.01 M $296 K +$1.45 M Oct 1, 2021 Dec 31, 2021 10-Q 2023-01-26
Q3 2021 $560 K -$149 K -$15 K -11.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-26
Q2 2021 $575 K $911 K +$239 K +35.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-27
Q1 2021 $336 K $952 K +$890 K +1435% Jan 1, 2021 Mar 31, 2021 10-K 2022-05-11
Q4 2020 -$554 K -$1.15 M -$1.35 M -704% Oct 1, 2020 Dec 31, 2020 10-Q 2022-01-26
Q3 2020 $791 K -$134 K -$329 K -169% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-26
Q2 2020 $1.12 M $672 K +$359 K +115% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-28
Q1 2020 $761 K $62 K -$181 K -74.5% Jan 1, 2020 Mar 31, 2020 10-K 2022-05-11
Q4 2019 $942 K $191 K +$191 K Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-11
Q3 2019 $751 K $195 K +$107 K +122% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $644 K $313 K +$168 K +116% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $476 K $243 K +$637 K Jan 1, 2019 Mar 31, 2019 10-K 2021-05-11
Q4 2018 -$161 K $0 +$213 K Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-10
Q3 2018 -$374 K $88 K +$353 K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$727 K $145 K -$940 K -86.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $213 K -$394 K -$280 K -246% Jan 1, 2018 Mar 31, 2018 10-K 2020-05-18
Q4 2017 $493 K -$213 K -$242 K -834% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-07
Q3 2017 $735 K -$265 K -$273 K -3413% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $1.01 M $1.09 M +$1.08 M +36067% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$74 K -$114 K -$114 K Jan 1, 2017 Mar 31, 2017 10-K 2019-05-24
Q4 2016 $40 K $29 K Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-13
Q3 2016 $8 K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 $3 K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 $0 Feb 3, 2016 Mar 31, 2016 10-K 2018-06-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.